Zoetis | ZTS - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
AbbVie USD 3.58B 316M 2026-03
Align Technology USD 465.34M 23.67M 2026-03
Bayer EUR 3.7B 356M 2026-03
Bristol-Myers Squibb USD 1.62B 564M 2026-03
Charles River Laboratories USD 159.42M 36.71M 2026-03
Coherus Biosciences USD 15M 6.26M 2025-12
Dentsply International USD 351M 32M 2026-03
Eli Lilly USD 2.93B 198M 2026-03
Henry Schein USD 809M 1000K 2026-03
Idexx Laboratories USD 299.85M 24.18M 2026-03
Illumina USD 272M 11M 2026-03
IQVIA Holdings USD 502M 34M 2026-03
J&J USD 6.03B 719M 2026-03
Laboratory Of America USD 551M 12.4M 2026-03
Merck USD 2.67B 180M 2026-03
Neogen USD 98.5M 9M 2025-12
Pacira USD 83.88M 7.99M 2026-03
Perrigo USD 267.3M 11.4M 2026-03
Pfizer USD 2.92B 1.16B 2026-03
Phibro Animal Health USD 78.32M 10.24M 2025-12
Quest Diagnostics USD 504M 0 2026-03
Sanofi EUR 2.33B 419M 2026-03
Sanofi EUR 2.75B 455M 2025-12
Zoetis USD 588M 31M 2026-03